Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AORT Artivion

交易中 10-02 11:12:24 EDT

22.26

+0.33

+1.48%

最高22.72	最低21.64	成交量10.24万
今开22.08	昨收21.93	日振幅4.92%
总市值10.85亿	流通市值10.30亿	总股本4,876万
成交额227.97万	换手率0.22%	流通股本4,627万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AORT","market":"US","secType":"STK","nameCN":"Artivion","latestPrice":22.255,"timestamp":1790953935597,"preClose":21.93,"halted":0,"volume":102373,"delay":0,"changeRate":0.014819881440948441,"floatShares":46265684,"shares":48756221,"eps":-0.066367,"marketStatus":"交易中","change":0.325,"latestTime":"10-02 11:12:24 EDT","open":22.075,"high":22.72,"low":21.64,"amount":2279690.693548,"amplitude":0.049248,"askPrice":22.29,"askSize":100,"bidPrice":22.16,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.066367,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"listingDate":868939200000,"exchange":"NYSE","adjPreClose":21.93,"postHourTrading":{"tag":"盘后","latestPrice":21.93,"preClose":21.93,"latestTime":"19:30 EDT","volume":37073,"amount":813019.16,"timestamp":1790897405953,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.846922,"impliedVol":0.2537,"impliedVolPercentile":0.1753},"requestUrl":"/m/hq/s/AORT","defaultTab":"news","newsList":[{"id":"1137768976","title":"财报前瞻｜Artivion本季度营收预计增11.16%，机构观点偏中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1137768976","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137768976?lang=zh_cn&edition=full","pubTime":"2026-07-31 03:58","pubTimestamp":1785441516,"startTime":"0","endTime":"0","summary":"Artivion将于2026年08月06日发布最新季度财报，市场关注收入增长与利润率修复的平衡。市场一致预期本季度Artivion营收为1.20亿美元，同比增长11.16%；调整后每股收益为0.01美元，同比增长333.10%；息税前利润为730.17万美元，同比下降0.39%。上季度Artivion营收为1.16亿美元，同比增长17.54%；毛利率为64.85%，归属母公司股东的净利润为141.70万美元，净利率为1.22%，调整后每股收益为0.03美元，同比增长400.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Artivion本季度营收预计增11.16%，机构观点偏中性","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190934796","title":"Artivion完成对Endospan的收购，此前Nexus®主动脉弓系统获FDA PMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1190934796","media":"美股速递","labels":["corporation","productRelease","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190934796?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:06","pubTimestamp":1779102394,"startTime":"0","endTime":"0","summary":"在Endospan公司旗下Nexus®主动脉弓系统获得美国食品药品监督管理局（FDA）上市前批准（PMA）后，Artivion公司宣布已完成对Endospan的收购交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4082","IE00B66KJ199.SGD","AORT","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156537568","title":"异动解读 | 分析师下调目标价，Artivion盘中暴跌35.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156537568","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156537568?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:56","pubTimestamp":1778248564,"startTime":"0","endTime":"0","summary":"Artivion今日盘中股价大跌35.54%，引起了市场的广泛关注。消息面上，华尔街分析师在周五发布的研究报告中下调了Artivion的目标股价。其中，Canaccord Genuity将Artivion的目标价从48美元下调至36美元，奥本海默亦将其目标价从50美元下调至38美元。分析师下调目标价通常反映了对公司未来盈利前景或估值的担忧，这直接影响了投资者的信心，导致了股价在盘中交易时段大幅下挫。Artivion是一家专注于心血管外科修复和重建的医疗设备公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176720657","title":"异动解读 | 分析师下调目标价，Artivion盘前暴跌28.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176720657","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176720657?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:26","pubTimestamp":1778246815,"startTime":"0","endTime":"0","summary":"医疗设备公司Artivion今日盘前股价出现大幅下跌，跌幅达28.66%，引起了市场的广泛关注。消息面上，华尔街分析师在周五发布的研究报告中下调了Artivion的目标股价。其中，Canaccord Genuity将Artivion的目标价从48美元下调至36美元，奥本海默亦将其目标价从50美元下调至38美元。分析师下调目标价通常反映了对公司未来盈利前景或估值的担忧，这直接影响了投资者的信心，导致了股价在盘前交易时段承压大幅下挫。Artivion是一家专注于心血管外科修复和重建的医疗设备公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138542411","title":"财报前瞻 ｜Artivion本季度营收预计增21.88%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1138542411","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138542411?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:28","pubTimestamp":1777534082,"startTime":"0","endTime":"0","summary":"Artivion将于2026年05月07日发布最新季度财报，市场关注NEXUS获批后的商业化节奏与盈利弹性。市场一致预期显示，本季度Artivion营收预计为美元1.16亿，同比增长21.88%；调整后每股收益预计为0.04美元，同比增长135.38%；息税前利润预计为美元763.67万，同比增长72.19%；公司层面未披露本季度毛利率与净利润或净利率的具体指引，季度收入指引在上一季度财报沟通中亦未单列。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Artivion本季度营收预计增21.88%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516376743","title":"Artivion, Inc.2024财年实现净利润-13.36百万美元，同比增加56.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516376743?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758444,"startTime":"0","endTime":"0","summary":"3月1日，Artivion, Inc.公布财报，公告显示公司2024财年净利润为-13.36百万美元，同比增加56.30%；其中营业收入为3.89亿美元，同比增加9.89%，每股基本收益为-0.32美元。从资产负债表来看，Artivion, Inc.总负债5.13亿美元，其中短期债务5.29百万美元，资产负债比为1.54，流动比率为0.04。机构评级：截至2025年3月1日，当前有6家机构对Artivion, Inc.目标价做出预测，其中目标均价为32.33美元，其中最低目标价为30.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000054abe0ffa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016991","title":"Citizens Capital Markets：重申Artivion(AORT.US)评级，由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016991","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514016991?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:41","pubTimestamp":1740498087,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：重申Artivion(AORT.US)评级，由优于大市调整至优于大市评级, 目标价由33.00美元调整至33.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25234148384497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090314","title":"Artivion, Inc.盘中异动 早盘急速跳水7.36%报25.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090314?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分，Artivion, Inc.股票出现异动，股价快速下挫7.36%。截至发稿，该股报25.80美元/股，成交量3747股，换手率0.01%，振幅0.07%。Artivion, Inc.股票所在的医疗器械行业中，整体跌幅为0.01%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223601abdc7f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0031619046.USD","BK4082","IE00B66KJ199.SGD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102635029","title":"异动解读 | Artivion营收不及预期 盘后大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102635029","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102635029?lang=zh_cn&edition=full","pubTime":"2025-02-25 06:02","pubTimestamp":1740434560,"startTime":"0","endTime":"0","summary":"医疗器械公司Artivion(AORT)周一盘后交易中大跌6.64%,因公司最新公布的第四季度业绩未达分析师预期。\n数据显示,Artivion第四季度销售额为9731万美元,较去年同期增长3.88%,但低于分析师预期的1.0082亿美元。季绩不佳导致资金撤离,引发Artivion盘后股价暴跌。\n分析人士指出,医疗器械行业竞争激烈,如果Artivion未来无法实现预期销售增长,将对公司业绩和股价造成进一步压力。市场将持续关注Artivion后续财报,评估其业务发展势头。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118685764","title":"Artivion第四季度调整后每股收益为$0，低于预期的$-0.06；销售额为$97.31M，低于预期的$100.82M","url":"https://stock-news.laohu8.com/highlight/detail?id=1118685764","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118685764?lang=zh_cn&edition=full","pubTime":"2025-02-25 05:21","pubTimestamp":1740432065,"startTime":"0","endTime":"0","summary":"Artivion  报告季度销售额为$97.31百万，比分析师的预期$100.82百万低3.48％。这比去年同期$93.67百万的销售额增长了3.88％。以上内容来自Benzinga Earnings专栏，原文如下：$Artivion$  reported quarterly sales of $97.31 million which missed the analyst consensus estimate of $100.82 million by 3.48 percent.  This is a 3.88 percent increase over sales of $93.67 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artivion第四季度调整后每股收益为$0，低于预期的$-0.06；销售额为$97.31M，低于预期的$100.82M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507458175","title":"Needham：重申Artivion(AORT.US)评级，由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507458175","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507458175?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:30","pubTimestamp":1738081842,"startTime":"0","endTime":"0","summary":"Needham：重申Artivion(AORT.US)评级，由买入调整至买入评级, 目标价由34.00美元调整至34.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29003047883380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503191879","title":"Artivion, Inc.盘中异动 股价大涨5.30%报31.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503191879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503191879?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:37","pubTimestamp":1737038253,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时37分，Artivion, Inc.股票出现波动，股价快速拉升5.30%。截至发稿，该股报31.65美元/股，成交量4.3507万股，换手率0.10%，振幅1.76%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.76%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223733abad50f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B66KJ199.SGD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484954369","title":"Artivion, Inc.2024财年第三财季实现净利润-2.29百万美元，同比增加76.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484954369?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:02","pubTimestamp":1731772953,"startTime":"0","endTime":"0","summary":"11月17日，Artivion, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.29百万美元，同比增加76.54%；其中营业收入为95.78百万美元，同比增加9.03%，每股基本收益为-0.05美元。从资产负债表来看，Artivion, Inc.总负债4.98亿美元，其中短期债务1.05亿美元，资产负债比为1.62，流动比率为1.56。机构评级：截至2024年11月17日，当前有6家机构对Artivion, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为32.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000322a23e064e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481310298","title":"Artivion, Inc.盘中异动 快速下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481310298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481310298?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077149,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分，Artivion, Inc.股票出现异动，股价急速下挫5.66%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为0.55%。其相关个股中，Tivic Health Systems, Inc.、Nexalin Technology Inc C/Wts 、Lensar, Inc.涨幅较大，Tivic Health Systems, Inc.、Bluejay Diagnostics, Inc.、Ainos, Inc.较为活跃，换手率分别为2786.95%、13.00%、9.91%，振幅较大的相关个股有Tivic Health Systems, Inc.、Clearpoint Neuro Inc.、Pacific Biosciences Of California, Inc.，振幅分别为84.61%、20.86%、19.18%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224549971a5623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B66KJ199.SGD","AORT","IE00B7SZL793.SGD","BK4082","IE0031619046.USD","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481983610","title":"Artivion, Inc.盘中异动 早盘大幅拉升5.74%报29.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481983610?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Artivion, Inc.股票出现异动，股价急速上涨5.74%。截至发稿，该股报29.49美元/股，成交量1.7448万股，换手率0.04%，振幅3.08%。Artivion, Inc.股票所在的医疗器械行业中，整体涨幅为1.59%。Artivion, Inc.公司简介：Artivion Inc 为心脏和血管外科医生提供一套主动脉为中心的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145971a4bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B7SZL793.SGD","IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","AORT","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivion.com","stockEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.1905},{"period":"3month","weight":-0.0851},{"period":"6month","weight":-0.3582},{"period":"1year","weight":-0.4666},{"period":"ytd","weight":-0.5192}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artivion, Inc.于1984年1月19日在佛罗里达州注册成立，并于2022年1月1日将其注册州从佛罗里达州改为特拉华州。该公司是制造、加工和分销用于主动脉疾病患者心脏和血管手术的医疗器械和可植入人体组织的领导者。该公司有四个主要产品系列：主动脉支架移植物、On-X机械心脏瓣膜和相关手术产品、手术密封剂以及植入式心脏和血管人体组织。","yearOnYearQuotes":[{"month":1,"riseRate":0.424242,"avgChangeRate":0.007066},{"month":2,"riseRate":0.484848,"avgChangeRate":0.004153},{"month":3,"riseRate":0.382353,"avgChangeRate":-0.011523},{"month":4,"riseRate":0.588235,"avgChangeRate":0.063852},{"month":5,"riseRate":0.5,"avgChangeRate":0.051494},{"month":6,"riseRate":0.676471,"avgChangeRate":0.03271},{"month":7,"riseRate":0.529412,"avgChangeRate":0.002385},{"month":8,"riseRate":0.5,"avgChangeRate":0.021887},{"month":9,"riseRate":0.617647,"avgChangeRate":0.027794},{"month":10,"riseRate":0.382353,"avgChangeRate":-0.030469},{"month":11,"riseRate":0.545455,"avgChangeRate":0.017167},{"month":12,"riseRate":0.515152,"avgChangeRate":0.022117}],"exchange":"NYSE","name":"Artivion","nameEN":"Artivion"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artivion,AORT,Artivion股票,Artivion股票老虎,Artivion股票老虎国际,Artivion行情,Artivion股票行情,Artivion股价,Artivion股市,Artivion股票价格,Artivion股票交易,Artivion股票购买,Artivion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artivion(AORT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artivion(AORT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}